Medication info
Valdipin Tablet 10/160 mg

Valdipin Tablet 10/160 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Kyungdong Pharmaceutical Co., Ltd.
Appearance
Bright yellow oval film-coated tablet
Packaging
28 tablets (7 tablets/Alu-Alu x 4), 30 tablets/bottle
Approval status
Active

MFDS item code 201308375 · Approved 2013.07.25 · Insurance code 648103290

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take this medicine at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using an individual component, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients receiving dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
Child dose
Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Ingredients

Manufacturer
Kyungdong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medicine is used to effectively manage the blood pressure of patients with essential hypertension whose blood pressure is not sufficiently controlled by single therapy with amlodipine or valsartan.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take this medicine at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using an individual component, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a fixed-dose combination containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients receiving dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.

Child dose

Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Precautions

This medicine may cause serious harm or even death to the fetus or newborn if administered to pregnant women in the second or third trimester, so it must be discontinued immediately upon confirmation of pregnancy. This medicine is contraindicated in certain patients, including those with allergies to the active ingredients or similar drugs, pregnant or nursing women, those with severe kidney or liver dysfunction, and patients with certain heart diseases. Caution is required in patients with sodium or fluid depletion in the body, hyperkalemia, renal artery stenosis, recent kidney transplant, history of vascular edema, patients with heart failure or who have had a myocardial infarction. Hypotension may occur during use, so if symptoms appear, lie down and rest immediately and seek appropriate treatment at a hospital if necessary. This medicine can cause various side effects such as headache, dizziness, fatigue, edema, indigestion, skin rash, so if unusual symptoms persist or are severe, consult a doctor. Caution is needed when driving or operating machinery as dizziness or fatigue may occur. This medicine may interact with other antihypertensive medications, potassium supplements, diuretics, and certain anti-inflammatory drugs, so it is essential to inform healthcare professionals about other medications being taken. Women who are pregnant or planning to become pregnant, or nursing mothers should avoid using this medicine for safety reasons. This medicine is not recommended for children under 18 years of age as its safety and efficacy have not been sufficiently established. In the elderly, it can be administered at the same doses as those for the general adult population, but the patient's physical condition should be monitored closely. In case of overdose, symptoms such as dizziness and severe hypotension may occur, so in the event of unintentional overdose, visit a medical institution immediately for appropriate treatment.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, pruritus, joint swelling, back pain, arthritis, muscle spasm, fatigue, polyuria, nocturia, erectile dysfunction, edema, lymphedema, facial swelling, peripheral edema, tiredness, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, vascular edema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, double vision, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory impairment, taste disturbance, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, vascular edema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturnal enuresis, gynecomastia, pain, lethargy, chest pain, weight loss, weight gain, elevated liver enzymes, chest pain, weight gain, arthralgia, somatic pain, rhabdomyolysis, gingival hyperplasia, gastritis, neuroexcitability, sensory impairment, Stevens-Johnson syndrome, dizziness, fatigue, rapid blood pressure drop, hypotension, pulmonary edema, decreased urine output, progressive azotemia, acute renal failure, death, angina, acute myocardial infarction, elevated serum potassium levels, increased blood urea and serum creatinine, abdominal pain, nausea, vomiting, diarrhea, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius. This will help keep the medicine effective for a longer period.

Appearance and packaging

Appearance

Bright yellow oval film-coated tablet

Package unit

28 tablets (7 tablets/Alu-Alu x 4), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.